# Novanta Inc > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Novanta Inc). ## Overview Novanta Inc. is a U.S.-based industrial technology company that supplies proprietary components and subsystems to original equipment manufacturers in medical and advanced industrial markets. Its portfolio includes motion control, laser beam delivery, machine vision, video processing, sensing, identification, and medical device technologies sold globally through direct sales and distribution channels. ## Products & services • Medical insufflators and endoscopic pumps • Laser beam delivery and motion control solutions • Video processing, streaming, and capture systems • Machine vision, RFID, barcode, and sensing technologies • Touch panel displays and light/color measurement tools • Advanced industrial OEM components and subsystems - **Medical Solutions** (53%) — Medical-grade technologies and subsystems used in surgical, diagnostic, and life science equipment. - **Advanced Industrial Solutions** (47%) — Precision technologies and components used in automation, manufacturing, and industrial OEM systems. - Medical insufflators and endoscopic pumps - Laser beam delivery and motion control solutions - Video processing, streaming, and capture systems - Machine vision, RFID, barcode, and sensing technologies - Touch panel displays and light/color measurement tools - Advanced industrial OEM components and subsystems ## Customers Novanta sells primarily to OEMs that integrate its technologies into medical devices and industrial equipment. Customers value application expertise, product performance, reliability, customization, and long design-in lifecycles, which can make supplier changes difficult once a product is adopted. The company also serves distributors and resellers in some channels, but direct technical selling remains central to the model. - **Medical OEMs** (primary) — Buy medical-grade subsystems and devices for surgical, diagnostic, and life science platforms; they need regulatory-ready, high-reliability components. - **Advanced industrial OEMs** (primary) — Buy precision technologies for automation, robotics, manufacturing, and inspection systems where performance and integration matter. - **Life science and healthcare providers via OEM channels** (secondary) — Indirect end demand for equipment used in hospitals, labs, and healthcare networks. - **Distributors and resellers** (secondary) — Purchase selected products to extend local market reach and support smaller accounts. - Medical OEMs integrating components into surgical and diagnostic systems - Life science and healthcare equipment makers needing precision subsystems - Advanced industrial OEMs building automation and manufacturing equipment - Customers that value design-in support, reliability, and customization - Distributors and resellers used in selected markets and geographies ## Geography Novanta sells products globally and maintains service and application centers in the United States, Europe, and Asia. The business has meaningful international exposure, with roughly 47% of revenue coming from customers outside the U.S., which makes foreign exchange, shipping, and cross-border supply chain execution important to operations. - **United States** (53%) — Derived from 2025 disclosure that approximately 47% of revenue came from customers outside the U.S. - **International** (47%) — Derived from 2025 disclosure that approximately 47% of revenue came from customers outside the U.S. - Global sales footprint across the United States, Europe, and Asia - Service and application centers support customer integration worldwide - About 47% of revenue comes from customers outside the U.S. - International exposure increases FX, logistics, and collection risk - Manufacturing operations are certified across quality and safety standards ## Strategy Novanta’s strategy centers on proprietary technology solutions for long-life OEM platforms in medical and advanced industrial niches. The company emphasizes improving its mix toward medical end markets, expanding application expertise, and using acquisitions and product development to deepen its technology stack and customer relationships. - **Deepen penetration in medical OEM platforms** (medium-term) — Medical programs tend to have long design cycles and sticky customer relationships. - **Strengthen proprietary technology breadth** (medium-term) — Broader technology coverage improves cross-selling and customer retention. - **Support global OEM customers with local technical presence** (short-term) — Application support and service proximity are key differentiators in design-in markets. - Focus on long-life OEM platforms with high switching costs - Increase medical exposure within the overall revenue mix - Use proprietary technology to solve complex application problems - Expand application centers and technical sales support globally - Pursue acquisitions that add technology, customers, or channels ## Risks Novanta faces demand cyclicality tied to medical capital spending, industrial production cycles, and OEM product launch timing. Its global footprint also exposes it to foreign exchange volatility, tariffs, supply chain disruption, cybersecurity incidents, and customer concentration, while goodwill and intangible assets require ongoing impairment judgment. - **Customer concentration** [high] — A small number of OEMs can represent a meaningful share of revenue, increasing dependence on their launch and purchasing decisions. - **Cyclical end-market demand** [high] — Medical and advanced industrial sales depend on customer capital budgets, procedure volumes, and manufacturing investment cycles. - **Trade policy and inflation** [medium] — Tariffs, retaliatory measures, and inflation can increase input costs and pressure pricing. - **Cybersecurity and IT disruption** [high] — Operational systems connect with customers and suppliers, so outages or breaches can interrupt revenue and create liability. - **Foreign exchange and international operations** [medium] — A large share of revenue is generated outside the U.S., creating translation and transaction exposure. - Customer concentration can create volatility if a large OEM slows orders - Medical and industrial demand depends on capital spending and cycles - Tariffs, inflation, and trade policy can raise manufacturing costs - Cybersecurity or IT outages could disrupt customers and suppliers - Foreign exchange and international operations add operational complexity - Goodwill and intangibles require impairment testing and judgment ## Accounting Revenue is recognized mainly at a point in time when control transfers, usually on shipment, while a smaller portion of professional services and service plans is recognized over time. Investors should also watch goodwill and intangible asset impairment testing, inventory valuation, and estimates tied to contingent consideration, taxes, and long-lived assets, since these can materially affect reported results. - **Revenue recognition timing** — Affects quarterly comparability and cutoff judgments - **Service plans and warranties** — Creates deferred revenue and timing differences - **Goodwill and intangible impairment** — Can create non-cash charges if performance weakens - **Inventory valuation** — May affect gross margin and working capital - **Income tax estimates** — Can cause volatility in effective tax rate - Most revenue is recognized on shipment, not over time - Service plans and warranties create deferred revenue timing effects - Professional services are a small but separate revenue stream - Goodwill and intangible assets require periodic impairment testing - Inventory, taxes, and contingent consideration rely on estimates --- *Last updated: 2026-04-29T04:40:35.913513+00:00*